Traditional Australian Aboriginal medicinal plants: An untapped resource for novel therapeutic compounds?

Future Medicinal Chemistry

Volumn 5, Issue 7, 2013, Pages 733-736

  Locher, Cornelia ^a   Semple, Susan J ^b   Simpson, Bradley S ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Aboriginal medicine; Australia; collaboration; intellectual property; pharmacopoeia; traditional knowledge

Indexed keywords

DITERPENOID; PLANT MEDICINAL PRODUCT;

ABORIGINE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; AUSTRALIA; BIODIVERSITY; HUMAN; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AUSTRALIA; BIOLOGICAL AGENTS; HUMANS; MEDICINE, TRADITIONAL; PLANT EXTRACTS; PLANTS, MEDICINAL; SAPINDACEAE; SKIN DISEASES;

EID: 84877613051     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.44     Document Type: Review

References (16)

1. Rasmussen M, Guo X, Wang Y, et al. An Aboriginal Australian genome reveals separate human dispersals into Asia. Science 334(6052), 94-98 (2011).
2. Barr A. Aboriginal communities of the Northern Territory of Australia. In: Traditional Bush Medicines. An Aboriginal Pharmacopoeia. Greenhouse Publications, Darwin, Australia (1988).
3. Ghisalberti EL. The chemistry of the unusual terpenoids from the genus Eremophila. Stud. Nat. Prod. Chem. 15, 225-287 (1995).
4. Pennacchio M, Syah YM, Ghisalberti EL, Alexander E. Cardioactive compounds from Eremophila species. J. Ethnopharmacol. 53(1), 21-27 (1996).
5. Liu Q, Harrington D, Kohen JL, Vemulpad S, Jamie JF. Bactericidal and cyclooxygenase inhibitory diterpenes from Eremophila sturtii. Phytochemistry 67(12), 1256-1261 (2006).
6. Anakok O, Ndi C, Barton M, Griesser H, Semple S. Antibacterial spectrum and cytotoxic activities of serrulatane compounds from the Australian medicinal plant Eremophila neglecta. J. Appl. Microbiol. 112, 197-204 (2012).
7. Laird S, Monagle C, Johnston S. Queensland Biodiscovery Collaboration: The Griffith University AstraZeneca Partnership for Natural Product Discovery - an access and benefit sharing case study. UNU-IAS, Yokohama, Japan (2008).
8. Liu Q, Harrington D, Kohen JL, Vemulpad S, Jamie JF. Bactericidal and cyclooxygenase inhibitory diterpenes from Eremophila sturtii. Phytochemistry 67(12), 1256-1261 (2006).
9. Brouwer N, Liu Q, Harrington D, et al. An ethnopharmacological study of medicinal plants in New South Wales. Molecules 10, 1252-1262 (2005).
10. Mills C, Carroll AR, Quinn RJ. Acutangulosides A-F, monodesmosidic saponins from the bark of Barringtonia acutangula. J. Nat. Prod. 68(3), 311-318 (2005).
11. Evans L, Briscoe J, Baker E, et al. Plants for people: laboratory study report. In: Desert Knowledge CRC. Report 56. Desert Knowledge CRC, Alice Springs, Australia (2010).
12. Claudie DJ, Semple SJ, Smith NM, Simpson BS. Ancient but new. Developing locally-driven enterprises based on traditional medicines in "Kuuku I'yu" (Northern Kaanju homelands, Cape York, Queensland, Australia). In: Indigenous Peoples' Innovation: IP Pathways to development, Drahos P, Frankel S (Eds). ANU ePress, Canberra, Australia (2012).
13. Simpson BS, Claudie DJ, Gerber JP, et al. In vivo activity of benzoyl ester clerodane diterpenoid derivatives from Dodonaea polyandra. J. Nat. Prod. 74(4), 650-657 (2011).
14. Chuulangun Aboriginal Corporation, University of South Australia: WO/2011/057332 (2011).
15. Department of sustainability, environment, water, population and communities (2009) biodiversity hotspots. www.environment.gov.au/biodiversity/ hotspots/index.html (Accessed 20 January 2013)
16. Australian Bureau of Statistics (2012) Year Book Australia. www.abs.gov.au/ausstats/absat.nsf/Lookup/by%20Subject/1301.0∼2012∼ Main%20 Features∼Home%20page∼1 (Accessed 20 January 2013)